Disseminated tumor cells as selection marker and monitoring tool for secondary adjuvant treatment in early breast cancer. Descriptive results from an intervention study

Documenti analoghi

• Persistence of disseminated tumor cells after neoadjuvant treatment for locally advanced breast cancer predicts poor survival
  di: Mathiesen, Randi R, et al.
  Pubblicazione: (2012)
• Low Z‐4OHtam concentrations are associated with adverse clinical outcome among early stage premenopausal breast cancer patients treated with adjuvant tamoxifen
  di: Helland, Thomas, et al.
  Pubblicazione: (2020)
• Comparison of molecular and immunocytochemical methods for detection of disseminated tumor cells in bone marrow from early breast cancer patients
  di: Gilje, Bjørnar, et al.
  Pubblicazione: (2014)
• Corrigendum to “Presence of bone marrow micrometastasis is associated with different recurrence risk within molecular subtypes of breast cancer” [Mol. Oncol. 1 (2007) 160–171]
  di: Naume, Bjørn, et al.
  Pubblicazione: (2010)
• Presence of bone marrow micrometastasis is associated with different recurrence risk within molecular subtypes of breast cancer
  di: Naume, Bjørn, et al.
  Pubblicazione: (2007)